. Mutations in either the ARS consensus sequence or the Bl element that reduce ORC binding also reduce origin function (Bell and Stillman, 1992; Rao and Stillman, 1995; Rowleyet al., 1995) . DNase I protection experiments using intact yeast nuclei suggest that ORC is bound to these sites in vivo (Diffley and Cocker, 1992; Diffley et al., 1994) . Yeast strains with mutations in the genes encoding ORC subunitsshow defects in DNA replication (Bell et al., 1993; Loo et al., 1995; Micklem et al., 1993) , and studiesof initia- Bell et al., 1993; Foss et al., 1993; Li and Herskowitz, 1993; Loo et al., 1995; Micklem et al., 1993) Bell et al., 1993; Bell and Stillman, 1992) . Purified ORC was separated by SDS-polyacrylamide gel electrophoresis, and individual subunits were excised, cleaved by lysyl endopeptidase, and sequenced as described prevrously (Loo et al., 1995) . Using the sequence from the longest peptide derived from Orcl p, Orc3p, and Orc4p as a guide, we synthesized degenerate oligos to amplify the genomic DNA that encoded the peptide. The resulting appropriately sized products were cloned, sequenced, and found to encode the appropriate peptide sequence. These DNA fragments were used to probe a yeast genomic library. Positive h subclones were subcloned and sequenced on both strands (ORC7, pl2O.FL; ORC3, p62.FL; ORC4, p56.9) . Additional peptide sequences were used to confirm that the correct open reading frame was identified. The DNA sequences encoding each protein have been deposited in GenBank.
Plasmid Construction N-terminal substitutions and deletions of ORC7 were constructed using a form of ORC7 with Ndel sites overlapping the initiator ATG and at position 706 bp downstream of the ATG (pSPBl.50). The second substitution changes amino acid 235 from glutamine to histidine and amino acid 236 from isoleucine to methionine. These changes did not effect either the silencing or essential function of ORCI. The deletion of the Orcl p NTD was constructed by cutting with Ndel and religating (pSPB1.48).
To replace the Orclp NTD with the Sir3p NTD, we used PCR to amplify the region of SIR3 encoding amino acids l-235, using primers that put Ndel sites at each end of the amplified fragment. After digestron with Ndel, the PCR product was ligated into the pSPB1.50 cut with Ndel (pSPB1.49).
To construct the N-terminal chimeras of SIR3, we engineered an Ndel site at the initiator ATG of SIR3 (pSIR3.7). The Ndel to Bglll fragment of this construct was substituted with a PCR fragment amplified from ORC7 that encoded the first 231 amino acids of Orclp with an Ndel site at the initiator ATG and a Bglll site at the 3' end of PCR product (pSIR3.12).
The N-terminal deletion of Sir3p was made by digesting pSIR3.7 with Ndel and 89111, filling in the ends, and religating the resulting large fragment (pSIR3.15). This resulted in the deletion of the N-terminal 241 amino acids of Sir3p. To substitute the the Cdcl8p/CdcGp-related region of Orclp into Sir3p, the region of ORC7 encoding amino acids 405-738 was PCR amplified. The resulting product was digested with Hindlll and Kpnl and inserted into the SIR3 gene cut with Hindlll and Kpnl, replacing amino acids 505-834 of Sir3p (pSIR3.13).
To substitute the C-terminal region of Sir3p into Orcl p, we PCR amplified the region of SIR3 encoding amino acids 557-779.
The resulting product was digested with EcoRl and Aflll and cloned into ORC7, replacing amino acids 457-680 of Orcl p (pSIR3.12).
All regions generated by PCR and the junctions between the genes were sequenced to assure that no point mutations were introduced during cloning and PCR amplification. Mutations in the two matches to the P loop consensus of Orclp were made by site-directed mutagenesis (K485E is pSB165; K732E is pSB163).
Plasmids for integrating
HMRaNVT or HMRal-RAP7 at the HIS3 locus were made as follows. pJR1426 (HMRaIWT) or pJR1425 (HMRal -RAPI) were cut with Notl and Sall and cloned into pRS403 (with a filled in BstEll site) digested with the same enzymes, creating pRS403/ HMRa and pRS403/HMRa/-RAP7, respectively.
Deletion of ORCl, ORC3, and ORC4 The ORC7 disruption was constructed by replacing the Ndel to Ncol fragment of ORC7 with the TRP7 gene (pSPB17). The ORC3 gene was disrupted by replacing the Hindlll to Clal fragment with the HIS3 gene (pSPB37).
The ORC4 gene was disrupted by replacing the Ndel to Hincll fragment of ORC4 with the TRP7 gene (pSPB47). In each case, a linearized fragment including the gene with the selectable marker replacing the indicated region of the gene was transformed into a diploid yeast strain. These strains were sporulated either before or after transforming with a plasmid containing a copy of appropriate wild-type gene (ORCI, pSPB16; ORC3, pSPB36; ORC4, pSPB46). For the strains lacking the plasmid, the only viable spores observed were unable to grow in the absence of tryptophan (ORC7 and ORC4) or histidine (ORC3). For diploid strains containing plasmid, spores were isolated that could grow in the absence of tryptophan (ORC7 and ORC4) or histidine (ORC3), but in each case the resulting haploid yeast were unable to grow without the plasmid, indicating that the wild-type copy of the gene was essential for mitotic growth.
Complementation,
Mating, and Plasmid Stability Assays To test for complementation of the essential function of ORC7 or of SIR3, we transformed eitherySPB1.13 (adeZ-7 ura3-7 his3-77, his3-75 trp7-7 IeuZ-3, IeuZ-772 canl-700 orc7::TRPI pSPBl6) or RS862 (ade2-7 ura3-7 his3-17, his3-75 trpl-7 leu2-3, leu2-7 72 canl-700 sir3:; TRPI) with a plasmid expressing the indicated form of ORC7 or SIR3. Complementation of the AORC7 phenotype was scored by testing for growth of the transformed strain on plates containing 5-fluoroorotic acid. Complementation of the AS/R3 phenotype was tested by measuring the mating efficiency of RS862 transformants. To test the ability of wild-type and mutant forms of ORC7 to function in mating-type silencing, we integrated each of the ORC7 constructs into the LEUP locus of ySPB1 .13 and the ORC7 wild-type plasmid was removed from the strain: ySB128 (full length), ySB129 (Sir3p NTD-ORC7 chimera), and ySB130 (ORC7A235).
Subsequently, a modified form of HMRa lacking the RAP7-binding site (pRS403IHMRalFRAAP7) was integrated into the HIS3 locus: ySB132(full length), ySB133(Sir3p NTD-ORC7 chimera), and ySB135 (ORC7A235). When the integrated HMRa locus is derepressed, both a and a information is expressed and the strain is unable to mate. Mating efficiencies were determined by growing the strain to be tested to approximately 1 x 10' cells per milliliter. Cells were diluted appropriately and plated directly on nonselective media to determine the exact cell count. A second lesser dilution was added to a culture of 217a cells (717~7, MATa), incubated together for 5-10 min, and plated onto media that selected for diplod cells. Mating efficiency was determined by dividing the number of cells that mated by the total number of cells. All mating assays were performed three or more times. Plasmid stabilities were performed as described previously (Marahrens and Stillman, 1992) . Loss rates per generation were calculated as described by McNally and Rine (1991) . The plasmid tested was pARSl/WT (Marahrens and Stillman, 1992 were amplified and plaque purified. To produce ORC in insect cells, we infected 200 ml of Sf9 cells (1 x IO" cells per milliliter) with 1 x lo9 pfu of each of the above viruses. The resulting synchronous infection was allowed to proceed for 40 hr, and nuclear extract was prepared from the infected cells. ORC was purified from these extracts as described previously (Bell et al., 1993) except that the DNA affinity column was omitted. The estimated yield from this preparation was 4 mg of pure ORC complex.
